16-1985976-C-G
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_005262.3(GFER):c.566C>G(p.Ser189*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_005262.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005262.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GFER | NM_005262.3 | MANE Select | c.566C>G | p.Ser189* | stop_gained | Exon 3 of 3 | NP_005253.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GFER | ENST00000248114.7 | TSL:1 MANE Select | c.566C>G | p.Ser189* | stop_gained | Exon 3 of 3 | ENSP00000248114.6 | ||
| GFER | ENST00000567719.2 | TSL:1 | c.341C>G | p.Ser114* | stop_gained | Exon 2 of 2 | ENSP00000455885.1 | ||
| GFER | ENST00000565658.1 | TSL:1 | n.723C>G | non_coding_transcript_exon | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152270Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 250730 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460762Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 726704 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152270Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74390 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome Pathogenic:1
Variant summary: GFER c.566C>G (p.Ser189X) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a known mechanism for disease. While this variant is not expected to result in nonsense mediated decay, it is predicted to disrupt the last 17 amino acids of the protein. Variants downstream of this position, such as p.Arg194His, have been reported in association with disease (HGMD database; PMIDs: 19409522, 28155230) and classified as pathogenic in ClinVar. The variant allele was found at a frequency of 2.8e-05 in 250730 control chromosomes (i.e., 7 heterozygotes, no homozygotes; gnomAD v2 Exomes dataset). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.566C>G in individuals affected with Congenital Cataract-Progressive Muscular Hypotonia-Hearing Loss-Developmental Delay Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at